We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Disease Diagnosis Based on Infrared Analysis of Blood Samples

By LabMedica International staff writers
Posted on 30 Mar 2021
A novel, infrared spectroscopy-based approach detects the status of a person’s health by monitoring changes in the molecular composition of blood samples. More...


Changes in an individuals health are reflected in characteristic modifications to the molecular composition of biofluids. Detecting these modifications could contribute to the detection of various disease states.

Toward this end, investigators at the Ludwig Maximilian University of Munich (Garching, Germany) and colleagues at the Max Planck Institute of Quantum Optics (Garching, Germany) used Fourier-transform infrared spectroscopy (FTIR) to “fingerprint” blood serum and plasma samples from healthy, non-symptomatic individuals.

The intent of the study was to address questions that are fundamental for the applicability of infrared fingerprinting in health monitoring, which means that the stability of the molecular patterns in healthy persons over time must be firmly established.

Initially, the investigators tested whether infrared spectral fingerprints could be obtained from bulk liquid blood serum and plasma samples in a direct and reproducible fashion. Then, they determined the range of natural biological variation of infrared fingerprints from individual volunteers over time (within-person variation). In addition, they related the variation of the IMFs over time for any given individual to the degree of variability between different individuals (between-person variation) and to operational variabilities inherent to clinical practice.

For this study, the investigators used FITR to fingerprint blood serum and plasma samples from 31 healthy, non-symptomatic individuals, who were sampled up to 13 times over a period of seven weeks and again after six months. The measurements were performed directly on liquid serum and plasma samples, yielding a time- and cost-effective workflow with a high degree of reproducibility.

Results revealed that the infrared molecular fingerprint of each individual donor remained stable over periods ranging from a few days to weeks and months, and that each temporal profile could be readily attributed to the participant concerned. Furthermore, single measurements yielded a multiplicity of person-specific spectral markers, allowing individual molecular phenotypes to be detected and followed over time.

"This newly revealed temporal stability of blood-based infrared fingerprints provides a basis for future applications of minimally invasive infrared spectroscopy as a reliable method for the future of health monitoring," said senior author Dr. Mihaela Žigman, head of the broadband infrared diagnostics group in the department of laser physics at the Ludwig Maximilian University of Munich. "Practically speaking, following-up a person's health status regularly might become paramount for timely-detecting relevant deviations. In addition to its uses in the fields of health monitoring and preventive medicine, systems biology shall also benefit from the availability of the approach."

The FITR study was published in the March 8, 2021, online edition of the journal Nature Communications.

Related Links:
Ludwig Maximilian University of Munich
Max Planck Institute of Quantum Optics



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Portable Electronic Pipette
Mini 96
Blood Glucose Test Strip
AutoSense Test
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.